(Date:12/2/2009)... , NANJING, China, Dec. 2 /PRNewswire-As...the "Company") (NYSE: SCR ), a leading pharmaceu...ufacturing, and marketing of branded,generic and p...ed that 105 of,its drugs have been included in Chi...ich was issued by China,s Ministry of Human Resour...
(Date:12/2/2009)... , SHANGHAI, Dec. 2 /PRNewswire-Asia/ --...arkets are in turmoil and uncertainty is part of m...he pharma industry has been,relatively immune to t... a,vacation. , During the midst of the di...Johnson & Johnson inaugurated an R&D cente...
(Date:12/2/2009)... , HOBOKEN, N.J., Dec. 2 Accor...nt to 45 percent of Americans diagnosed with diabe...y. Diabetic retinopathy, damage to the retina cau...indness in people with diabetes and is one of the ...o 80 percent of all patients who,ve had diabetes f...
(Date:12/1/2009)..., INCLINE VILLAGE, Nev., Dec. 1 /PRNewswire-Fir...I ) today announced revenue guidance for the fourt... $57 million, as compared with $69 million for the...r 2008 results was the first of two installment pa...ed in fourth quarter 2008 results was a one-time $...
Breaking Biology Technology:Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3(Date:12/3/2009)...and BANGALORE, India, December 3 A...product and application,development services, toda...ft BioIT Alliance to extend its services focus int...rapidly evolving industry to leverage Aditi,s,supe...wledge and best,practices know-how. , Thi...
(Date:12/3/2009)...I, December 3 After two decades of...eir field, Lightlake Therapeutics, experts,have be... gene testing,subjects for a trial of a simple, sa...th Organisation has described as a global epidemic...se II trial for the everyday treatment against obe...
(Date:12/2/2009)... 2 Reportlinker.com announces that...catalogue: ,, Arthroscopes - A World Market Re...Arthroscopes---A-World-Market-Review.html ,, ...to their mounting scope and usage in the diagnosis... apart from knees. The number of arthroscopic shou...
Breaking Medicine Technology:Aditi Technologies Join Hands With Microsoft BioIT Alliance to Offer Solutions in Bioinformatics Space 2Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland 2Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland 3Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland 4Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland 5Reportlinker Adds Arthroscopes - A World Market Review 2Reportlinker Adds Arthroscopes - A World Market Review 3Reportlinker Adds Arthroscopes - A World Market Review 4Reportlinker Adds Arthroscopes - A World Market Review 5Reportlinker Adds Arthroscopes - A World Market Review 6Growth in German children 8924 1VA Reopening Health Care Enrollment to Thousands of Veterans 49475 1VA Reopening Health Care Enrollment to Thousands of Veterans 49475 2Sinovac Receives Chinas First Influenza A 28H1N1 29 Vaccine Order 12708 1Sinovac Receives Chinas First Influenza A 28H1N1 29 Vaccine Order 12708 2Sinovac Receives Chinas First Influenza A 28H1N1 29 Vaccine Order 12708 3